Inflamed Tissue

"Inflamed tissue" refers to regions in the body where an active inflammatory response is ongoing. This includes the accumulation of immune cells (especially neutrophils, macrophages, and lymphocytes) that migrate from the bloodstream into tissue through extravasation to fight infection, clear debris, and initiate repair[4][3]. The process involves a complex network of cytokines, chemokines, and cellular signaling pathways, notably including the activation of inflammasomes (e.g., NLRP3 and NLRP6) and Toll-like receptors[2][5]. Inflamed tissue is not a discrete molecular entity, so it cannot be classified as a receptor, enzyme, transporter, or other molecular target. Instead, it is a pathological state or an anatomical location that can be the focus of drug delivery or disease study, but not a direct molecular target. Consequently, specific drugs or biomarkers may be associated with molecular events in inflamed tissue, but not with "inflamed tissue" itself. In summary, "inflamed tissue" is a pathological state, not a molecule or receptor; therefore, it is inappropriate to treat it as a canonical drug target or molecular classification.

Other names

Inflamed areaInflammatory tissueSite of inflammation